Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: A longitudinal (REACTION) study

被引:170
作者
Bi, Yufang [1 ,2 ]
Lu, Jieli [1 ,2 ]
Wang, Weiqing [1 ,2 ]
Mu, Yiming [4 ]
Zhao, Jiajun [5 ]
Liu, Chao [6 ]
Chen, Lulu [8 ]
Shi, Lixin [10 ]
Li, Qiang [11 ]
Wan, Qin [12 ]
Wu, Shengli [13 ]
Yang, Tao [7 ]
Yan, Li [14 ]
Liu, Yan [15 ]
Wang, Guixia [15 ]
Luo, Zuojie [16 ]
Tang, Xulei [17 ]
Chen, Gang [18 ]
Huo, Yanan [19 ]
Gao, Zhengnan [20 ]
Su, Qing [3 ]
Ye, Zhen [21 ]
Wang, Youming [22 ]
Qin, Guijun [23 ]
Deng, Huacong [24 ]
Yu, Xuefeng [9 ]
Shen, Feixia [25 ]
Chen, Li [26 ]
Zhao, Liebin [1 ,2 ]
Zhang, Jie [1 ,2 ]
Sun, Jichao [1 ,2 ]
Dai, Meng [1 ,2 ]
Xu, Min [1 ,2 ]
Xu, Yu [1 ,2 ]
Chen, Yuhong [1 ,2 ]
Lai, Shenghan [27 ]
Bloomgarden, Zachary T. [28 ]
Li, Donghui [29 ]
Ning, Guang [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrine & Metab Dis,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200025, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[5] Shandong Prov Hosp, Jinan, Peoples R China
[6] Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China
[7] Nanjing Univ, Sch Med, Nanjing 210008, Jiangsu, Peoples R China
[8] Huazhong Univ Sci & Technol, Sch Med, Wuhan Xiehe Hosp, Wuhan 430074, Peoples R China
[9] Wuhan Tongji Hosp, Wuhan, Peoples R China
[10] Guizhou Univ, Sch Med, Guiyang 550003, Peoples R China
[11] Univ Haerbin, Sch Med, Harbin, Peoples R China
[12] Univ Luzhou, Sch Med, Luzhou, Peoples R China
[13] Xinjiang Kelamayi Peoples Hosp, Kelamayi, Peoples R China
[14] Zhongshan Univ, Sch Med, Guangzhou, Guangdong, Peoples R China
[15] Jilin Univ, Sch Med, Changchun 130023, Peoples R China
[16] Guangxi Univ, Sch Med, Nanning 530004, Peoples R China
[17] Lanzhou Univ, Sch Med, Lanzhou 730000, Peoples R China
[18] Univ Fujian, Sch Med, Fuzhou, Peoples R China
[19] Jiangxi Peoples Hosp, Nanchang, Peoples R China
[20] Dalian Univ, Sch Med, Dalian 116012, Peoples R China
[21] Zhejiang Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China
[22] Anhui Univ, Sch Med, Hefei 230039, Peoples R China
[23] Univ Zhenzhou, Sch Med, Zhengzhou, Peoples R China
[24] Chongqing Univ, Sch Med, Chongqing 630044, Peoples R China
[25] Wenzhou Univ, Sch Med, Wenzhou, Peoples R China
[26] Univ Shangdong, Sch Med, Qilu Hosp, Jinan, Peoples R China
[27] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[28] Mt Sinai Sch Med, New York, NY USA
[29] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
基金
国家高技术研究发展计划(863计划); 中国国家自然科学基金;
关键词
cancer; diabetes; REACTION study; MORTALITY; METFORMIN; MELLITUS;
D O I
10.1111/1753-0407.12108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo demonstrate whether abnormal glucose metabolism (diabetes and prediabetes) is associated with increased risk for cancer in the Chinese population and to identify factors that modify the risk of cancer among individuals with abnormal glucose metabolism. MethodsBetween 2011 and 2012, 259657 community-dwelling adults, aged 40 years and older, were recruited from 25 centers across mainland China to participant in the baseline survey of the REACTION study, with follow-up investigations performed 3, 5, and 10 years later. Detailed questionnaires about lifestyles, physical and biochemical measurement, bio-samples including serum, urine, and whole blood for DNA extraction were collected for all the participants. ResultsThe mean standard deviation (SD) age of this cohort was 5710 years. And the prevalence of pre-existing and newly diagnosed diabetes was 10.32% and 10.57%, respectively. A total of 4511 prevalent cancer cases (988 men and 3523 women) were identified, the prevalence was 1.79. Compared to those with normal glucose metabolism, men with diabetes had a significantly lower adjusted prevalence ratio (PR) of stomach cancer (PR: 0.38, 95% CI: 0.16-0.89), and women with diabetes had significantly higher adjusted PRs of cancer of all sites (PR: 1.36, 95% CI: 1.20-1.56), and cancer of the breast (PR: 1.56, 95% CI: 1.21-2.00), the endometrium (PR: 1.58, 95% CI: 1.16-2.15), and the thyroid (PR: 1.53, 95% CI: 1.03-2.27). ConclusionThe multi-center REACTION study has captured a broad range of data on physical, psychological and metabolic function as well as health status, biochemical and lifestyle information in 259657 adults from the general population across the China.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 27 条
  • [1] The metabolic syndrome - a new worldwide definition
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. LANCET, 2005, 366 (9491) : 1059 - 1062
  • [2] [Anonymous], WHO STEPWISE APPR CH
  • [3] Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
    Bodmer, Michael
    Meier, Christian
    Krahenbuehl, Stephan
    Jick, Susan S.
    Meier, Christoph R.
    [J]. DIABETES CARE, 2010, 33 (06) : 1304 - 1308
  • [4] Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
    Bowker, SL
    Majumdar, SR
    Veugelers, P
    Johnson, JA
    [J]. DIABETES CARE, 2006, 29 (02) : 254 - 258
  • [5] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
    Calle, EE
    Rodriguez, C
    Walker-Thurmond, K
    Thun, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) : 1625 - 1638
  • [6] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [7] The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    Currie, C. J.
    Poole, C. D.
    Gale, E. A. M.
    [J]. DIABETOLOGIA, 2009, 52 (09) : 1766 - 1777
  • [8] Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
    Elashoff, Michael
    Matveyenko, Aleksey V.
    Gier, Belinda
    Elashoff, Robert
    Butler, Peter C.
    [J]. GASTROENTEROLOGY, 2011, 141 (01) : 150 - 156
  • [9] Gavin JR, 1997, DIABETES CARE, V20, P1183
  • [10] Diabetes and Cancer A consensus report
    Giovannucci, Edward
    Harlan, David M.
    Archer, Michael C.
    Bergenstal, Richard M.
    Gapstur, Susan M.
    Habel, Laurel A.
    Pollak, Michael
    Regensteiner, Judith G.
    Yee, Douglas
    [J]. DIABETES CARE, 2010, 33 (07) : 1674 - 1685